Coeptis Therapeutics Holdings, Inc. (COEPW) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
105 BRADFORD ROAD, SUITE 420 WEXFORD, PA 15090 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2836 - Biological Products, Except Diagnostic Substances (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |||
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash, cash equivalents, and short-term investments | 1,469 | 3,791 | 404 | 907 | |||
| Cash and cash equivalent | 1,469 | 3,791 | 404 | 907 | |||
| Receivables | 39 | 8 | |||||
| Prepaid expense | 242 | 142 | 8 | 52 | |||
| Total current assets: | 1,750 | 3,942 | 413 | 959 | |||
| Noncurrent Assets | |||||||
| Operating lease, right-of-use asset | 98 | 59 | |||||
| Property, plant and equipment | 11 | 13 | |||||
| Long-term investments and receivables | 75,759 | 75,751 | |||||
| Long-term investments | 75,759 | 75,751 | |||||
| Intangible assets, net (including goodwill) | 2,554 | 3,554 | |||||
| Intangible assets, net (excluding goodwill) | 2,554 | 3,554 | |||||
| Prepaid expense | 158 | ||||||
| Other undisclosed noncurrent assets | 348 | ||||||
| Total noncurrent assets: | 2,821 | 3,974 | 75,759 | 75,751 | |||
| TOTAL ASSETS: | 4,571 | 7,916 | 76,171 | 76,710 | |||
| LIABILITIES AND EQUITY | |||||||
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts payable and accrued liabilities, including: | 1,976 | 281 | 140 | 5 | |||
| Accounts payable | 1,420 | 99 | |||||
| Accrued liabilities | 556 | 182 | 5 | ||||
| Other undisclosed accounts payable and accrued liabilities | 140 | ||||||
| Debt | 975 | 1,850 | |||||
| Derivative instruments and hedges, liabilities | |||||||
| Other liabilities | |||||||
| Other undisclosed current liabilities | 38 | 42 | |||||
| Total current liabilities: | 2,989 | 2,173 | 140 | 5 | |||
| Noncurrent Liabilities | |||||||
| Long-term debt and lease obligation | 150 | 150 | |||||
| Long-term debt, excluding current maturities | 150 | 150 | |||||
| Liabilities, other than long-term debt | 618 | 1,140 | 2,250 | ||||
| Deferred revenue | 2,250 | ||||||
| Operating lease, liability | 61 | 15 | |||||
| Derivative instruments and hedges, liabilities | 557 | 1,125 | |||||
| Other undisclosed noncurrent liabilities | 7,047 | 20,700 | |||||
| Total noncurrent liabilities: | 768 | 1,290 | 7,047 | 22,950 | |||
| Total liabilities: | 3,757 | 3,462 | 7,187 | 22,955 | |||
| Temporary equity, including noncontrolling interest | 75,759 | 75,751 | |||||
| Equity | |||||||
| Equity, attributable to parent, including: | 814 | 4,453 | (6,774) | (21,996) | |||
| Preferred stock | |||||||
| Common stock | 4 | 2 | 25 | 25 | |||
| Additional paid in capital | 91,667 | 70,541 | |||||
| Accumulated deficit | (87,356) | (66,090) | (6,799) | (22,021) | |||
| Stockholders' equity note, subscriptions receivable | (3,500) | ||||||
| Other undisclosed equity, attributable to parent | |||||||
| Equity, attributable to noncontrolling interest | |||||||
| Total equity: | 814 | 4,453 | (6,774) | (21,996) | |||
| TOTAL LIABILITIES AND EQUITY: | 4,571 | 7,916 | 76,171 | 76,710 | |||
Income Statement (P&L) ($ in thousands)
| 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | ||
|---|---|---|---|---|---|---|
| Revenues (Other Income) | 99 | |||||
| Gross profit: | 99 | |||||
| Operating expenses | (21,491) | (34,196) | (681) | (68) | ||
| Other undisclosed operating loss | (99) | |||||
| Operating loss: | (21,491) | (34,196) | (681) | (68) | ||
| Nonoperating income (expense) | 225 | (3,378) | 0 | |||
| Other nonoperating income (expense) | (220) | 0 | ||||
| Interest and debt expense | (108) | (3,394) | ||||
| Loss from continuing operations before equity method investments, income taxes: | (21,374) | (40,968) | (681) | (68) | ||
| Other undisclosed income from continuing operations before income taxes | 108 | 3,394 | ||||
| Loss from continuing operations before income taxes: | (21,267) | (37,574) | (681) | (68) | ||
| Other undisclosed income from continuing operations | ||||||
| Loss from continuing operations: | (21,267) | (37,574) | (681) | (68) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | (681) | (68) | |
| Other undisclosed net loss | (17,211) | |||||
| Net loss: | (21,267) | (37,574) | (681) | (17,279) | ||
| Net loss attributable to noncontrolling interest | ||||||
| Other undisclosed net income (loss) attributable to parent | 15,911 | (0) | ||||
| Net income (loss) attributable to parent: | (21,267) | (37,574) | 15,229 | (17,280) | ||
| Preferred stock dividends and other adjustments | (6,682) | (75,751) | ||||
| Net income (loss) available to common stockholders, diluted: | (21,267) | (37,574) | 8,547 | (93,031) | ||
Comprehensive Income ($ in thousands)
| 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | ||
|---|---|---|---|---|---|---|
| Net loss: | (21,267) | (37,574) | (681) | (17,279) | ||
| Comprehensive loss: | (21,267) | (37,574) | (681) | (17,279) | ||
| Comprehensive loss, net of tax, attributable to noncontrolling interest | ||||||
| Comprehensive loss, net of tax, attributable to parent: | (21,267) | (37,574) | (681) | (17,279) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.